Summary
The National Institutes of Health (NIH) is forecasting a funding opportunity (RFA) for early- and late-stage clinical trials addressing the full spectrum of Alzheimer's Disease (AD), Alzheimer's Disease-Related Dementias (ADRD), and age-related cognitive decline. This is a federal grant opportunity posted on Grants.gov. The opportunity is currently in a forecasted status, meaning full details including eligibility, award amounts, and submission requirements have not yet been published. It is expected to open around late June 2025.